KCT0003508招募中未知
Association of single nucleotide polymorphism with Korean female hair and scalp characteristics
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 25(Year) 至 39(Year)（—）
- 性别
- Female
入选标准
- •For women aged 25 to 39 years (normal or female type hair loss)
- •- A volunteer who understands the necessity and process of this study and agrees in writing to participate
- •- who can be tested blood sampling
排除标准
- •If you have a history of damage to your scalp
- •If you have a previous diagnosis of alopecia except for female type hair loss
- •(E.g., alopecia areata, telogen effluvium, scarring alopecia, and etc.)
- •If you have severe acute kidney or heart disease or other chronic diseases (hypertension, diabetes, etc.)
- •If you are suffering from hemorrhagic-like diseases such as hemophilia
- •If you are pregnant
- •If you are currently suffering from acute illness
- •If you have a reason that is difficult to collect blood
- •If the hair has been subjected to perming, dyeing, etc. during the last 3 months
研究者
相似试验
招募中
不适用
A study to determine whether the renalase gene is associated with chronic kidney disease.CTRI/2014/09/004964The Madras Medical Mission1,000
招募中
不适用
To assess association of genetic markers in the MMP genes with hypertensioCTRI/2014/12/005241The Madras Medical Mission Hospital
已完成
不适用
The Relationship of single nucleotide polymorphisms in the Interleukin-7 receptor-alpha gene to CD4+ immune recovery in HIV infected patients who begin antiretroviral treatment with HAARTThe determinants of immune recovery following institution of Highly Active Antiretroviral Treatment in HIV infected patientsInfection - Acquired immune deficiency syndrome (AIDS / HIV)ACTRN12605000495628HMRC110
招募中
不适用
To assess association of genetic markers in the renalase gene with hypertension.CTRI/2017/07/009144The Madras Medical Mission Hospital
进行中（未招募）
不适用
Single nucleotide polymorphism association with response and toxic effects in patients with Ph+ CP-CML treated with bosutinib after relapse or intolerance to previous treatment.EUCTR2013-004323-37-ESFundación PETHEMA para el tratamiento de la leucemia y el linfoma50